Answers are grounded in this paper and cite their sources.
Angiogenesis has developed into a major area of cancer research. Recently, several newly identified signalling pathways have been shown to play a role in both normal and pathological (including tumour) angiogenesis. Several of the molecules involved in these pathways have potential as novel anti-cancer therapeutic targets including members of the ephrin/Eph receptor, Notch/delta, sprouty, hedgehog and roundabout/slit families. These developments are reviewed.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: